Evidence map›Paper›PMID 26024091›Full record

ArticleInvestigative ophthalmology & visual science2015

Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye.

Wennan Lu, HuiLing Hu, Jean Sévigny, B'Ann T Gabelt, Paul L Kaufman, Elaine C Johnson, John C Morrison, Gulab S Zode, Val C Sheffield, Xiulan Zhang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. The P2X7 Receptor Regulates IL-1β Secretion in the Human Retina.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. ATP-P2XJournal of neuroinflammation · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Adenosine receptors as promising targets for the management of ocular diseases.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Wennan LuDepartment of Anatomy and Cell Biology, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
HuiLing HuDepartment of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States 3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China.
Jean SévignyDépartement de Microbiologie-Infectiologie et D'immunologie, Faculté de Médecine, Université Laval, and Centre de Recherche du CHU de Québec, Québec, Québec, Canada.
B'Ann T GabeltDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States.
Paul L KaufmanDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States.
Elaine C JohnsonKenneth C. Swan Ocular Neurobiology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States.
John C MorrisonKenneth C. Swan Ocular Neurobiology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States.
Gulab S ZodeHoward Hughes Medical Institute, University of Iowa, Iowa City, Iowa, United States 8Department of Cell Biology and Immunology, University of North Texas Health Science Center, Fort Worth, Texas, United States.
Val C SheffieldHoward Hughes Medical Institute, University of Iowa, Iowa City, Iowa, United States.
Xiulan ZhangState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China.
Alan M LatiesDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Claire H MitchellDepartment of Anatomy and Cell Biology, University of Pennsylvania, Philadelphia, Pennsylvania, United States 2Department of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
University of Pennsylvania · USOregon Health & Science University · USSun Yat-sen University · CNUniversity of Iowa · USUniversity of Wisconsin–Madison · USUniversité Laval · CA

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Geoffrey Karl Aguirre · 1985 to 2026
$19.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
STUDIES IN GLAUCOMATOUS OPTIC NERVE DAMAGER01EY010145 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORRISON, JOHN C · 1993 to 2023
$8.9M
Purines and the Health of Retinal Ganglion CellsR01EY015537 · NEI · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL, CLAIRE H · 2005 to 2023
$6.7M
REGULATION OF LYSOSOMAL PH IN RPE CELLSR01EY013434 · NEI · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL, CLAIRE H · 2002 to 2020
$5.3M
MOLECULAR GENETICS OF HEREDITARY GLAUCOMAR01EY010564 · NEI · UNIVERSITY OF IOWA · PI SHEFFIELD, VAL C. · 1994 to 2010
$4.7M
ANTERIOR OCULAR SEGMENT PHYSIOLOGY AND PHARMACOLOGYR01EY002698 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI KAUFMAN, PAUL L · 1985 to 2009
$4.5M
Novel Glaucoma Treatment Using Genome EditingR01EY024259 · NEI · UNIVERSITY OF IOWA · PI CLARK, ABBOT FREDERICK, SHEFFIELD, VAL C. · 2014 to 2018
$2.6M
The Optic Nerve Head in GlaucomaR01EY016866 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI JOHNSON, ELAINE C · 2005 to 2008
$1.4M
EXCITATORY AMINO ACIDS IN GLAUCOMAR01EY010009 · NEI · UNIVERSITY OF PENNSYLVANIA · PI LATIES, ALAN M · 1993 to 2004
$1.3M
Role of ER Stress in the Pathogenesis of Primary Open Angle GlaucomaR00EY022077 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZODE, GULAB · 2014 to 2016
$740k
Canadian Institutes of Health Research MOP-93683Howard Hughes Medical InstituteNEI NIH HHS EY001583NEI NIH HHS EY010145NEI NIH HHS EY013434NEI NIH HHS EY015537NEI NIH HHS EY016665NEI NIH HHS EY016866NEI NIH HHS EY022077NEI NIH HHS EY02698NEI NIH HHS EY10009NEI NIH HHS EY10564NEI NIH HHS K99 EY022077NEI NIH HHS P30 EY001583NEI NIH HHS P30 EY010572NEI NIH HHS P30 EY016665NEI NIH HHS R00 EY022077NEI NIH HHS R01 EY002698NEI NIH HHS R01 EY010009NEI NIH HHS R01 EY010145NEI NIH HHS R01 EY010564NEI NIH HHS R01 EY013434NEI NIH HHS R01 EY015537NEI NIH HHS R01 EY016866NEI NIH HHS R01 EY024259
6 · The paper itself

Abstract

purposeThe cellular mechanisms linking elevated IOP with glaucomatous damage remain unresolved. Mechanical strains and short-term increases in IOP can trigger ATP release from retinal neurons and astrocytes, but the response to chronic IOP elevation is unknown. As excess extracellular ATP can increase inflammation and damage neurons, we asked if sustained IOP elevation was associated with a sustained increase in extracellular ATP in the posterior eye.

methodsNo ideal animal model of chronic glaucoma exists, so three different models were used. Tg-Myoc(Y437H) mice were examined at 40 weeks, while IOP was elevated in rats following injection of hypertonic saline into episcleral veins and in cynomolgus monkeys by laser photocoagulation of the trabecular meshwork. The ATP levels were measured using the luciferin-luciferase assay while levels of NTPDase1 were assessed using qPCR, immunoblots, and immunohistochemistry.

resultsThe ATP levels were elevated in the vitreal humor of rats, mice, and primates after a sustained period of IOP elevation. The ecto-ATPase NTPDase1 was elevated in optic nerve head astrocytes exposed to extracellular ATP for an extended period. NTPDase1 was also elevated in the retinal tissue of rats, mice, and primates, and in the optic nerve of rats, with chronic elevation in IOP.

conclusionsA sustained elevation in extracellular ATP, and upregulation of NTPDase1, occurs in the posterior eye of rat, mouse, and primate models of chronic glaucoma. This suggests the elevation in extracellular ATP may be sustained in chronic glaucoma, and implies a role for altered purinergic signaling in the disease.

Indexed as

Disease Models, AnimalAdenosine TriphosphateAnimalsAntigens, CDApyraseCell CountChronic DiseaseFemaleGlaucomaImmunoblottingImmunohistochemistryIntraocular PressureMacaca fascicularisMaleMiceMice, Inbred C57BLAdenosine TriphosphateAntigens, CDApyraseCD39 antigen

Identifiers

PMID26024091
PMCPMC4439132
OpenAlexW2403879662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.